Kidney stones form as aggregates of various mineral phases, but calcium oxalate monohydrate (COM) is the most prevalent. Prior research efforts have failed to identify either a urine test that identifies stone formers or effective therapies preventing stone formation. We hypothesize that macromolecules in the urine of normal healthy adults prevent the pathologic aggregation events that lead to kidney stone formation, and that stone formers manifest some alteration in this protective mechanism. In this revised application, we propose to use a combination of bulk crystallization and microscopic characterization methods to identify specific chemical structural features of macromolecules that lead to a defect in aggregation inhibition, through a research protocol with two Specific Aims. The two Specific Aims are: (1) to use previously established bulk crystallization methods to study single macromolecules (from either biological or chemical origins) and combinations of polyanions and polycations to identify the chemical structural features critical to the COM aggregation processes and (2) to use atomic force microscopy to directly measure the influence of macromolecules studied under Aim 1 on the force of adhesion at specific COM crystal faces. In the later phases of these studies, we will use atomic force microscopy to measure directly the adhesion force between oriented crystal surfaces in the presence of various macromolecules in solution. The use of AFM will provide important information about the adsorption of macromolecules containing specific chemical functional groups with selected COM surfaces, that is not obtainable in any other way. Our preliminary data have shown important correlations between face selective binding and crystal phase and morphology. Extending the linkage of specific chemical functional groups to the aggregation process will allow for the intelligent design of drugs that could prevent stone formation by blocking aggregation processes. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK068551-01A2
Application #
7142926
Study Section
Urologic and Kidney Development and Genitourinary Diseases Study Section (UKGD)
Program Officer
Rasooly, Rebekah S
Project Start
2006-08-01
Project End
2009-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
1
Fiscal Year
2006
Total Cost
$219,687
Indirect Cost
Name
Medical College of Wisconsin
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Rimer, Jeffrey D; Kolbach-Mandel, Ann M; Ward, Michael D et al. (2017) The role of macromolecules in the formation of kidney stones. Urolithiasis 45:57-74
Viswanathan, Pragasam; Rimer, Jeffrey D; Kolbach, Ann M et al. (2011) Calcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall protein. Urol Res 39:269-82
Goldfarb, David S (2011) Potential pharmacologic treatments for cystinuria and for calcium stones associated with hyperuricosuria. Clin J Am Soc Nephrol 6:2093-7
Rimer, Jeffrey D; An, Zhihua; Zhu, Zina et al. (2010) Crystal growth inhibitors for the prevention of L-cystine kidney stones through molecular design. Science 330:337-341
An, Zhihua; Lee, Soolim; Oppenheimer, Harry et al. (2010) Attachment of calcium oxalate monohydrate crystals on patterned surfaces of proteins and lipid bilayers. J Am Chem Soc 132:13188-90